Walmart And Sam’s Pharmacies Dispensing COVID-19 Antiviral Medication

TEXAS, Dec. 30, 2021 – Walmart and Sam’s Club pharmacies will begin dispensing the authorized COVID antiviral medication, Paxlovid, and Molnupiravir, in Texas through the U.S. Federal Retail Pharmacy Therapeutics Program starting Dec. 30, 2021. Select Walmart and Sam’s Club pharmacies are receiving limited supplies of the COVID-19 antiviral medication. The medication is only available with a prescription from a healthcare provider.

Customers and healthcare providers can go to and use the store locator to find their nearest store or club carrying this medication to send the electronic prescription. Since healthcare providers prescribe the COVID-19 antiviral drugs to those with COVID-19, it will only be available at Walmart and Sam’s Club by curbside pickup or via drive-thru pharmacy windows.

Walmart worked closely with the federal government and state health departments to select locations where states determined they needed it the most. While initial treatment supply is limited, Walmart and Sam’s Club pharmacies stand ready to help expand treatment access nationwide. “We are committed to working with our state and federal partners to provide access to new treatment options like authorized COVID-19 antiviral medications as they become available,” said Kevin Host, senior vice president of pharmacy. 

“This offers customers the option to recover at home and helps reduce the burden on our hospitals and communities. In addition, as we have since the beginning of the pandemic, we’re proud to support our communities through everyday essentials, healthy food, vaccines, medication, and other health care needs as we all work together to weather the pandemic.”

Walmart and Sam’s Club pharmacies will continue to support states and the federal government to help increase the access and availability of authorized COVID-19 antiviral medication and COVID-19 vaccines. In addition, Walmart will continue to make flu vaccines and other preventative vaccines available. To stay up-to-date on how Walmart and Sam’s Club support the COVID-19 vaccine rollout, visit

You can find more information about these new medications to help treat COVID-19 here –

● F.D.A. News Release: F.D.A. Authorizes First Oral Antiviral for Treatment of COVID-19

● Paxlovid E.U.A. Letter of Authorization

● Frequently Asked Questions on the Emergency Use Authorization for Paxlovid

● Molnupiravir E.U.A. Letter of Authorization

● Frequently Asked Questions on the Emergency Use Authorization for Molnupiravir or death; 

MOLNUPIRAVIR: The drug is not approved, but the F.D.A. has authorized it for emergency use under E.U.A. to treat mild-to-moderate COVID-19. It is for adults with positive results of

direct SARS-CoV-2 viral testing and at high risk for progression to severe COVID-19. That includes hospitalization or death for whom alternative COVID-19 treatment options authorized by the F.D.A. are not accessible or clinically appropriate.

The F.D.A. only authorizes the emergency use of PAXLOVID and Molnupiravir for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1) unless the F.D.A. terminates the declaration or revokes the authorization sooner.

Comments are closed, but trackbacks and pingbacks are open.